Thailand - Delayed Quote THB

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (JSP.BK)

1.8100
0.0000
(0.00%)
At close: May 9 at 4:38:18 PM GMT+7
Loading Chart for JSP.BK
  • Previous Close 1.8100
  • Open 1.8200
  • Bid --
  • Ask --
  • Day's Range 1.8100 - 1.8400
  • 52 Week Range 1.6000 - 4.2200
  • Volume 95,100
  • Avg. Volume 308,707
  • Market Cap (intraday) 858.981M
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 181.00
  • EPS (TTM) 0.0100
  • Earnings Date --
  • Forward Dividend & Yield 0.06 (3.49%)
  • Ex-Dividend Date Aug 28, 2024
  • 1y Target Est --

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. develops, produces, and sells pharmaceutical, dietary supplementary, traditional medicine, and herbal products in Thailand. It also involved in manufacturing and selling hemodialysis products and supplies, purified water systems for industrial purposes, and related medical supplies; and service of laboratory research, scientific test and analysis, training and seminar, and consultancy for research fund application businesses. The company was founded in 1954 and is based in Bangkok, Thailand.

www.jsppharma.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: JSP.BK

View More

Performance Overview: JSP.BK

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

JSP.BK
10.40%
MSCI WORLD (^990100-USD-STRD)
0.19%

1-Year Return

JSP.BK
56.79%
MSCI WORLD (^990100-USD-STRD)
9.31%

3-Year Return

JSP.BK
69.86%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

JSP.BK
80.74%
MSCI WORLD (^990100-USD-STRD)
80.01%

Compare To: JSP.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: JSP.BK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    858.98M

  • Enterprise Value

    1.12B

  • Trailing P/E

    181.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.04

  • Price/Book (mrq)

    1.00

  • Enterprise Value/Revenue

    1.36

  • Enterprise Value/EBITDA

    24.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.54%

  • Return on Assets (ttm)

    4.80%

  • Return on Equity (ttm)

    -3.66%

  • Revenue (ttm)

    845.93M

  • Net Income Avi to Common (ttm)

    4.52M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    29.49M

  • Total Debt/Equity (mrq)

    32.68%

  • Levered Free Cash Flow (ttm)

    38.83M

Research Analysis: JSP.BK

View More

Company Insights: JSP.BK

Research Reports: JSP.BK

View More

People Also Watch